At J&J, I manage the Invega portfolio across Trinidad and Tobago, Aruba and Curaçao. Before that, at Apotex, I managed respiratory, urology, antibiotic and pain management portfolios, contributing to brand growth of 17% in FY 2024 and 25% in FY 2025.
Earlier, I published medical technology stories and interviews for Korea Biomedical Review and contributed to public health projects at Trinidad and Tobago’s Ministry of Health. My background also includes biomedical equipment maintenance and an MSc in Bioengineering from Seoul National University.

